Over 90
local business identities have stepped up to the challenge.
4,000
attendees have supported these champions on fight night.
$1 million
has been raised to support eight
local charities.
What is the Corporate Clash?
The Corporate Clash is all about coming together to learn, understand and support the life challenges of our community members in most need.
By getting behind the brave individuals who put themselves on the line on fight night, we can raise vital funds and awareness for Australians doing it tough.
With your support, our community can help ensure no one has to face their rare cancer journey alone.
Donate to a Fighter
or
Donate to the event
Fighters
Total amount raised
$98,735
Help us to reach our $90,000 goal
Craig Robinson just donated $38.33- Macarthur Colonics just donated $52.92
- Gaffney’s just donated $54.12
- Macarthur Lymphatics just donated $106.12
- Christian & Jessica Cirillo just donated $54.12
- David Patrick just donated $620.00
- Trema Civil just donated $520.00
- Wayne McClelland just donated $106.12
- Richard Sweetman just donated $54.12
- Katen Hansen just donated $54.12
- Kirstan Lusk just donated $27.81
- Craig McGlynn just donated $38.33
- simon mcnamara just donated $106.12
- Lina Judd just donated $11.65
- Sharon Ferns just donated $22.58
- Mardy and Pop Newman just donated $106.12
- Bernadette Canty just donated $11.65
- Melissa Duncombe just donated $54.12
- Mark Clarke just donated $106.12
- Naomi Chisholm just donated $22.10
Leaderboard
No Australian should have to go through their cancer journey alone
In Australia, over 160,000 people are expected to be diagnosed with cancer in 2024.
For those told they are "rare", information and treatment options are limited, and mortality is high. It can be a very lonely and uncertain journey.
RCA is the only charity in Australia that specialises in supporting people impacted by rare, less common, and complex cancers.
Every dollar raised will help more Australians receive expert guidance, information and support to help tackle the complex challenges that a rare cancer diagnosis can bring.
